Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Crawl-delay: |
Title | Bridge Medicines – Accelerating the Path to the |
Description | MEET BRIDGE Toggle Navigation About Our Model Team Management Board of Directors Scientific Advisory Board Pipeline Partners News Contact Loading... ACCELERATING THE |
Keywords | N/A |
WebSite | bridgemedicines.com |
Host IP | 209.182.208.223 |
Location | United States |
Site | Rank |
US$1,244,487
Last updated: 2023-05-08 21:36:46
bridgemedicines.com has Semrush global rank of 8,504,954. bridgemedicines.com has an estimated worth of US$ 1,244,487, based on its estimated Ads revenue. bridgemedicines.com receives approximately 143,595 unique visitors each day. Its web server is located in United States, with IP address 209.182.208.223. According to SiteAdvisor, bridgemedicines.com is safe to visit. |
Purchase/Sale Value | US$1,244,487 |
Daily Ads Revenue | US$1,149 |
Monthly Ads Revenue | US$34,463 |
Yearly Ads Revenue | US$413,553 |
Daily Unique Visitors | 9,573 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
bridgemedicines.com. | A | 300 | IP: 209.182.208.223 |
bridgemedicines.com. | NS | 86400 | NS Record: ns-114.awsdns-14.com. |
bridgemedicines.com. | NS | 86400 | NS Record: ns-1501.awsdns-59.org. |
bridgemedicines.com. | NS | 86400 | NS Record: ns-1819.awsdns-35.co.uk. |
bridgemedicines.com. | NS | 86400 | NS Record: ns-757.awsdns-30.net. |
bridgemedicines.com. | MX | 300 | MX Record: 10 bridgemedicines-com.mail.protection.outlook.com. |
bridgemedicines.com. | TXT | 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
bridgemedicines.com. | TXT | 300 | TXT Record: MS=ms84139076 |
Toggle Navigation About Our Model Team Management Board of Directors Scientific Advisory Board Pipeline Partners News Contact Loading... ACCELERATING THE PATH TO THE PATIENT Advancing promising early technologies from major academic institutions for the treatment of disease toward human proof of concept through accelerated drug discovery. LEARN MORE Home margaret 2021-06-01T10:24:22-04:00 MEET BRIDGE MEDICINES Bridge Medicines biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. Our mission is to move breakthrough research to the patient by bringing the best in modern drug discovery to the service of academic medicine. LEARN MORE OUR MODEL OUR TEAM RECENT NEWS Barbara Evans 2021-07-28T13:33:44-04:00 Bridge Medicines Enters Exclusive License Agreement with Cornell University for UBR5 Inhibitor |
HTTP/1.1 406 Not Acceptable Server: nginx/1.21.3 Date: Sat, 30 Oct 2021 18:05:19 GMT Content-Type: text/html; charset=iso-8859-1 Content-Length: 300 Connection: keep-alive |
Domain Name: BRIDGEMEDICINES.COM Registry Domain ID: 2054790845_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2020-04-14T18:05:02Z Creation Date: 2016-08-24T12:38:18Z Registry Expiry Date: 2025-08-24T12:38:18Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-114.AWSDNS-14.COM Name Server: NS-1501.AWSDNS-59.ORG Name Server: NS-1819.AWSDNS-35.CO.UK Name Server: NS-757.AWSDNS-30.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T04:21:51Z <<< |